Greedy Insider · Filing
AEON · 13D amendment · Daewoong Co., Ltd. and affiliates
Daewoong Co., Ltd. and affiliates reported a 30.6% stake in AEON Biopharma, Inc. (AEON) in a Schedule 13D amendment filed on Nov 10, 2026, triggered by an event on Oct 30, 2026.
Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001213900-26-117881